LEVODOPA AND CARBIDOPA (RYTARY) Nursing Considerations

What is the generic name?

LEVODOPA AND CARBIDOPA

What is the Trade Name for LEVODOPA AND CARBIDOPA?

RYTARY

What are the Indications for LEVODOPA AND CARBIDOPA?

• 1 INDICATIONS AND USAGE RYTARY is indicated for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. RYTARY is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication ( 1 )

References: https://open.fda.gov/